Nathaniel R Wilson

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Locally Advanced

Chronic Lymphocytic Leukemia

Prostate Cancer

Hematopoietic Stem Cell

Top Venues

Leukemia & lymphoma

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Leo, Eleonora Dondossola, Kaitlin J Basham, Nathaniel R Wilson, Omar Alhalabi, Jianjun Gao, Katherine C Kurnit, Michael G White, Jennifer Leigh McQuade, Shannon Neville Westin, Elizabeth A Wellberg, Daniel E Frigo
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer. Endocrinology (2023)
Nathaniel R Wilson, Yusuf Acikgoz, Elshad Hasanov
Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options. International journal of cancer (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D D DiNardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Nathaniel R Wilson, Naveen Pemmaraju
Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Expert opinion on pharmacotherapy 23 (4) (2022)
Ugochi Ebinama, Nathaniel R Wilson, Anindita Ghosh, Binsah S George
Therapeutic Management of Chronic Lymphocytic Leukemia Presenting with Recurrent Massive Ascites. Current oncology (Toronto, Ont.) 29 (10) (2022)
Naveen Pemmaraju, Nathaniel R Wilson, Guillermo Garcia-Manero, Koiji Sasaki, Joseph D Khoury, Nitin Jain, Gautam Borthakur, Farhad Ravandi, Naval G Daver, Tapan Kadia, Courtney D D DiNardo, Elias Jabbour, Sherry Pierce, Muzaffar Qazilbash, Marina Y Konopleva, Hagop Kantarjian
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD. Blood advances 6 (10) (2022)
Naveen Pemmaraju, Nathaniel R Wilson, Theresa Clementi Doan, Wei Qiao, Susan K Peterson, Vicky Zoeller, Andrew Schorr, Srdan Verstovsek
Myeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era. Leukemia & lymphoma 62 (9) (2021)
Nathaniel R Wilson, Laura Bover, Marina Konopleva, Lina Han, Sattva Neelapu, Naveen Pemmaraju
CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies. Leukemia & lymphoma (2021)
Omar Alhalabi, Matthew T Campbell, Lianchun Xiao, Ana C Adriazola, Nathaniel R Wilson, Arlene O Siefker-Radtke, Paul G Corn, Amado Zurita, Eric Jonasch, Jianjun Gao, Mehrad Adibi, Ashish M Kamat, Neema Navai, Louis L Pisters, Colin Dinney, Surena F Matin, Amishi Y Shah
Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma. BJUI compass 3 (1) (2021)
Nathaniel R Wilson, Hong Fang, Sanam Loghavi, Wei Wang, Guilin Tang, Rodney O Haltom, Caitlin R Rausch, Kenneth L McClain, Koneti V Rao, Uday R Popat, Luis E Fayad, Naly Champa, Katherine R Calvo, Carl E Allen, Tapan M Kadia, Naveen Pemmaraju
Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation. British journal of haematology 192 (3) (2020)